Indo Safe Pharma Private Limited
About Indo Safe Pharma Private Limited
Data last updated:
Indo Safe Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the service-based operations segment of the business services sector. It was incorporated on 21 August 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2017PTC298797. Its GSTIN is 08AAECI6019G1ZN (Rajasthan).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Jai Kumar Mittal and Sanjay Mittal.
Its last annual general meeting (AGM) was held on 05 August 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.12 Cr, a growth of 4% compared to the previous year. For the same year it recorded a net profit of ₹4.28 Lakh (net margin 1.4%) and EBITDA of ₹5.72 Lakh (EBITDA margin 1.8%). Revenue has grown at a compounded annual rate (CAGR) of 18% over three years.
The company has about 74 employees on its provident fund (EPFO) records.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Indo Safe Pharma Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered Address103 Kiran Building – D Parsi Panchayat Road, Near Sona Udyog Mogra Village, Mumbai, Maharashtra, India – 400069
- IndustryBusiness Services, Other Services, Miscellaneous Business Activities
To see the full contact details of Indo Safe Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Indo Safe Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Indo Safe Pharma Private Limited, buy the company report.
Financials of Indo Safe Pharma Private Limited
FY 2025 filings availableIndo Safe Pharma Private Limited reported revenue of ₹3.12 Cr (up 4% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 18% over three years, including 4% growth in the latest year. EBITDA rose 157% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹5.72 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹4.28 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.8% | ||||
| Net Profit Margin | 1.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Indo Safe Pharma Private Limited, buy the company report.
Board of directors of Indo Safe Pharma Private Limited
Indo Safe Pharma has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jai Kumar Mittal | Director | 21 Aug 2017 | 9 Years 2 Months | Current |
| Sanjay Mittal Also directs: Indo Safe Healthcare LLP | Director | 21 Aug 2017 | 9 Years 2 Months | Current |
| Shailesh Mittal Also directs: Gaurav Overseas Private Limited | Director | 21 Aug 2017 | 9 Years 2 Months | Current |
Peer comparison
Indo Safe Pharma Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Animal Pharma), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Cheerans Lab Pvt Ltd | ₹3.31 Cr (FY 2024) | -13.0% | Thrissur, Kerala, India | |||
| Bio Care India Private Limited | ₹3.22 Cr (FY 2023) | -83.0% | Nagpur, Maharashtra, India | |||
| Indo Safe Pharma Private Limitedthis company | ₹3.12 Cr (FY 2025) | ₹4.28 Lakh | 1.4% | 4.0% | 74 | Mumbai, Maharashtra, India |
| Dishika Biotech Private Limited | ₹2.94 Cr (FY 2025) | -2.0% | Ahmedabad, Gujarat, India | |||
| Marion Pharma India Private Limited | ₹2.85 Cr (FY 2025) | -4.0% | Guwahati, Assam, India |
To see the full peer comparison of Indo Safe Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Indo Safe Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Indo Safe Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Indo Safe Pharma Private Limited has a workforce of 74 employees on its EPFO records as of Mar 31, 2024, across 1 active EPFO establishment.
GST
Indo Safe Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 08AAECI6019G1ZN | Rajasthan | Active | 30 Jul 2021 |
To see the full GST registrations and return filing status of Indo Safe Pharma Private Limited, buy the company report.
Recent activity
Indo Safe Pharma Private Limited has 3 board changes on record since 2017: 3 appointments. The latest: Jai Kumar Mittal was appointed as Director on 21 Aug 2017.
Frequently asked questions
Indo Safe Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in other services, within the business services industry. It was incorporated on 21 August 2017 (9+ years old) and is registered under CIN U74999MH2017PTC298797.
Indo Safe Pharma has 3 current directors:
- Jai Kumar Mittal - Director
- Sanjay Mittal - Director
- Shailesh Mittal - Director
The latest financial statements of Indo Safe Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 05 August 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Indo Safe Pharma is 08AAECI6019G1ZN, registered in Rajasthan.
The CIN (Corporate Identification Number) of Indo Safe Pharma is U74999MH2017PTC298797. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Indo Safe Pharma was incorporated on 21 August 2017, making it 9+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Indo Safe Pharma by revenue are Cheerans Lab Pvt Ltd, Bio Care India Private Limited, Dishika Biotech Private Limited, Marion Pharma India Private Limited, all in the Pharma industry (Animal Pharma), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Jai Kumar Mittal was appointed as Director on 21 Aug 2017. Sanjay Mittal was appointed as Director on 21 Aug 2017. Shailesh Mittal was appointed as Director on 21 Aug 2017.
The registered office of Indo Safe Pharma is at 103 Kiran Building – D Parsi Panchayat Road, Near Sona Udyog Mogra Village, Mumbai, Maharashtra, India – 400069.
Indo Safe Pharma operates in the business services industry, in the other services segment.
The compliance status of Indo Safe Pharma is compliant as of 16 July 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
